cb2r genes (Revvity)
Structured Review
Cb2r Genes, supplied by Revvity, used in various techniques. Bioz Stars score: 90/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb2r+genes/Membrane+Target+Systems%3A+Cannabinoid+CB2+(human)+membrane+preparation/pm29229226-309-13-20
Average 90 stars, based on 14 article reviews
Images
Related Articles
Binding Assay:Article Title: New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking Article Snippet: Please cite this article as: G. Ragusa, M. Gómez-Cañas, P. Morales, C. Rodríguez-Cueto, M.R.. Pazos, B. Asproni, E. Cichero, P. Fossa, G.A.. Pinna, N. Jagerovic, J. Fernández-Ruiz, G. Murineddu, New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking, European Journal of Medicinal Chemistry (2017), doi: 10.1016/j.ejmech.2017.01.002. Article Title: Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB 1 receptor ligand antagonists. Article Snippet: A series of sulfenamide and sulfonamide derivatives was synthesized and evaluated for the affinity at CB1 and CB2 receptors.. The N-bornyl-S-(5,6-di-p-tolylpyridazin-3-yl)-sulfenamide, compound 11, displayed good affinity and high selectivity for CB1 receptors (Ki values of 44.6 nM for CB1 receptors and > 40 μM for CB2 receptors, respectively).. The N-isopinocampheylsulfenamide 12 and its sulfonamide analogue 22 showed similar selectivity for CB1 receptors with Ki values of 75.5 and 73.2 nM, respectively. Transfection:Article Title: New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking Article Snippet: Please cite this article as: G. Ragusa, M. Gómez-Cañas, P. Morales, C. Rodríguez-Cueto, M.R.. Pazos, B. Asproni, E. Cichero, P. Fossa, G.A.. Pinna, N. Jagerovic, J. Fernández-Ruiz, G. Murineddu, New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking, European Journal of Medicinal Chemistry (2017), doi: 10.1016/j.ejmech.2017.01.002. Article Title: Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB 1 receptor ligand antagonists. Article Snippet: A series of sulfenamide and sulfonamide derivatives was synthesized and evaluated for the affinity at CB1 and CB2 receptors.. The N-bornyl-S-(5,6-di-p-tolylpyridazin-3-yl)-sulfenamide, compound 11, displayed good affinity and high selectivity for CB1 receptors (Ki values of 44.6 nM for CB1 receptors and > 40 μM for CB2 receptors, respectively).. The N-isopinocampheylsulfenamide 12 and its sulfonamide analogue 22 showed similar selectivity for CB1 receptors with Ki values of 75.5 and 73.2 nM, respectively. |
